A tighter archive for life-science signals.
Search once, then narrow by source or topic.
BCI retinal implant medtech Science closes major $230M series C round
BCI retinal implant medtech Science closes major $230M series C round
Nvidia dives deeper into medtech, cancer research with Droplet Biosciences
Nvidia dives deeper into medtech, cancer research with Droplet Biosciences
Angelini nocks an AI arrow with $120M Quiver Bioscience deal
Angelini nocks an AI arrow with $120M Quiver Bioscience deal
Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site
European investment firm Gimv calls it quits on new life science financing
European investment firm Gimv calls it quits on new life science financing
Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
Pfizer CEO lays blame for US vaccine woes on RFK Jr.'s 'anti-science' stance: WSJ
JPM26: Chugai chases new science and name recognition from US biopharma industry
JPM26: Chugai chases new science and name recognition from US biopharma industry
Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects
Thermo Fisher Scientific teams up with Nvidia, TetraScience for next-gen AI workflow projects
<a href="https://www.fiercebiotech.com/research/cdc-instructs-researchers-end-all-monkey-studies-year-end-science" hreflang="en">CDC instructs researchers to end all monkey studies by year-end: Science</a>
The CDC is instructing scientists to end all research involving monkeys by the end of the year, in a move that will impact around 200 macaques and an unknown number of...
<a href="https://www.fiercebiotech.com/biotech/gilead-hatches-400m-biobucks-deal-swedish-biotechs-trex1-cancer-program" hreflang="en">Gilead hatches $400M biobucks deal for Swedish biotech’s TREX1 cancer program</a>
Swedish biotech Sprint Bioscience is selling off an early-stage TREX1 cancer program to Gilead for $14 million upfront, plus the chance to net up to $400 million in bio...
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page